Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page
- Check6 days agoChange DetectedThe page no longer shows the topic 'Multiple Myeloma' and omits the related topic 'MedlinePlus Genetics'. This reduces the disease-focused context and keyword associations used for discovery.SummaryDifference0.3%

- Check13 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma (a core medical topic).SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a MedlinePlus Genetics topic for multiple myeloma, expanding core content with genetics information about this disease.SummaryDifference0.1%

- Check28 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check35 days agoChange DetectedThe page now centers on the topic of Multiple myeloma with an updated version tag v3.1.0, replacing older, more granular terms and older revision v3.0.2.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.